International Speakers

Hajar M. Al Hayyan, MBBS

Riyadh, Saudi Arabia

Consultant Pulmonary Medicine and
Severe Airway Diseases
King Abdulaziz Medical City
Ministry of National Guard Health Affairs

Nashmia Almutairi, MD

Riyadh, Saudi Arabia

Deputy Chairman, Department of Oncology
Section Head, Division of Gynecology Oncology
King Abdulaziz Medical City
Ministry of National Guard Health Affairs

Dr. Roberto Badagliacca, MD, PhD

Italy

Dr. Roberto Badagliacca is an associate professor of cardiology at Sapienza University of Rome.
My research focus during and following my medical training has been on pulmonary arterial hypertension. I received advanced clinical and research training in cardiovascular diesease, cardiovascular imaging, and advanced heart failure. Since my appointment as Associate Professor of Cardiology, I have developed a specific interest in studying the pathophysiology, imaging phenotyping and risk stratification of pulmonary arterial hypertension. My research experience has culminated in the inclusion in the Nucleus of the ESC Working Group on Pulmonary Circulation & Right Ventricular Function, in a variety of peer-reviewed publications in the area and the inclusion as a Task Force Member of important Guidelines and Consensus documents Committees:
Guidelines for the “Diagnosis and Treatment of Pulmonary Hypertension” for the European Society of Cardiology and European Respiratory Society (2020-2022); Consensus Statement on “Peri-operative Management of Patients with Pulmonary Hypertension and Right Heart Failure Undergoing Surgery” for the International Society of Heart and Lung Transplantation (2020-2022); Consensus Statement on “Risk Stratification in Pulmonary Arterial Hypertension” for the International Society of Heart and Lung Transplantation (2022).

Hussein S. Al Juwayed, MD

Riyadh, Saudi Arabia

Consultant Pulmonary & Sleep Medicine
Head, Asthma and Airway Diseases Unit
Director, Adult Pulmonary Fellowship Program
Division of Pulmonary Medicine
Department of Medicine
Prince Sultan Military Medical City

Doaa Gad, MBBS

Riyadh, Saudi Arabia

Consultant pulmonary Medicine
Mouwasat Hospital

Shaden Qasrawi, MBBS, MSc (Resp Med), MRCP, SCE (Resp)

Riyadh, Saudi Arabia

Consultant Pulmonology and Sleep Medicine
Kingdom Hospital

Bashayr M. Alotaibi, MD

Riyadh, Saudi Arabia

Assistance Professor of Medicine
Consultant Pulmonology and Airway diseases
King Saud University Medical City

Wael F. Albalawy, MD, SFAAI , FEAACI

Riyadh, Saudi Arabia

Consultant Allergy & Immunology
King Saud Medical City

Fatmah Alhabeeb, MD

Riyadh, Saudi Arabia

Assistance Professor of Medicine
Consultant Pulmonology and Airway diseases
King Saud University Medical City

Rayyan M. ALMusally, MD

Dammam, Saudi Arabia

Assistant Professor of Medicine
Consultant Pulmonary Medicine
Imam Abdulrahman bin Faisal University

Fahad M. Alobaid, MD

Riyadh, Saudi Arabia

Consultant Pulmonary Medicine
Interstitial Lung Disease
Department of Medicine
King Faisal Specialist Hospital &Research Center

Kaine Teme, BSc-RRT, MPH

Dubai, UAE

Clinical Education Manager MEA-T
ResMed EPN Ltd

Mohmmed A. Algamdi, MBBS, FRCPC, ABIM, MHSc

Riyadh, Saudi Arabia

Consultant Pulmonary Medicine & Critical Care Medicine
Interstitial Lung Disease
King Fahad Medical City

Lamia G. Jamjoom, M.D, ABR

Jeddah, Saudi Arabia

Assistant Professor of Radiology
President, Radiological Society of Saudi Arabia
Consultant in cardiovascular and thoracic imaging
King Abdulaziz University Hospital

Sultan A. Qanash

Jeddah, Saudi Arabia

Assistant professor of Medicine
Consultant in Pulmonary and Sleep Medicine
Director, Sleep Disorder Laboratory
College of Medicine
King Saud Bin Abdul-Aziz University for Health Sciences

Noura Alturaif, MD

Riyadh, Saudi Arabia

Associate Consultant
Transplant Pulmonology and Pulmonary Hypertension
Lung Health Department
King Faisal Specialist Hospital & Research Center

Waleed Alharbi, MBBS, FRCPC, MPH

Riyadh, Saudi Arabia

Consultant Interventional Cardiologist
Director of King Fahad Cardiac Center
King Saud University Medical City

Rand K Arnaout, MBBS, FAAP, FAAAAI, ABP

Riyadh, Saudi Arabia

Assistant Professor (adj.)
College of Medicine, Alfaisal University
Head/ Consultant Allergy & Immunology
Department of Medicine
King Faisal Specialist Hospital &Research Center

Prof. Richard Gísli Jenkins PhD FRCP FERS

UK

Gisli Jenkins is a respiratory physician and cell & molecular biologist studying how the lung responds to injury to understand what drives progressive pulmonary fibrosis rather healing, repair and regeneration. He is an NIHR Research Professor, he leads the Margaret Turner Warwick Centre for Fibrosing Lung Diseases at the National Heart and Lung Institute and is an honorary consultant physician at the Royal Brompton Hospital, London.

Prof. Federico Lavorini, MD, PhD

Italy

Federico Lavorini is a Professor of Respiratory Medicine and Head of the Respiratory and Critical Care Unit at the Department of Clinical and Experimental Medicine, University of Florence, Italy. He qualified in Medicine at the University of Florence (1991), has the Specialist Certification in Respiratory Medicine (1996), and he also undertook a Ph.D. board certified in Respiratory Pathophysiology (2000).

His research interests are cough pathophysiology and aerosol medicine, particularly the study of effectiveness of inhaler devices and their use by asthma and COPD in a real-life setting. Since 2022, Federico Lavorini has published over 150 peer-reviewed papers and 80 of them are in the field of aerosol medicine. He has extensive experience in both academic and industrial pharmaceutics, and still retains a strong link with the pharmaceutical industry.

Recently, he patented a powder formulation of an antitussive drug deliverable by means of a capsule-based dry powder inhaler. Federico Lavorini is a member of the Aerosol Drug Management Improvement Team (ADMIT), an european consortium of respiratory physician with special interests in aerosol medicine.

Federico Lavorini is Chairman of the Italian Respiratory Society (SIP) Taskforce on aerosol delivery systems; he was also Co-Chair of the Global Consortium of Standards for Inhaler Errors, an initiative by the Imperial College London, UK. Federico Lavorini is Associate Editor and Review Editor of the Respiratory Physiology and Pathophysiology, Frontiers in Physiology, and Canadian Respiratory Journal. Federico Lavorini acts as board member of the Journal of Aerosol Medicine and Pulmonary Drug Delivery and he is a contributor and reviewer for the Journal.

Federico Lavorini presented several invited lectures on aerosol medicine topics in international meetings of the European Respiratory Society, American Thoracic Society, International Society of Aerosol Medicinea, RDD and DDL amomg others.

Prof. Pierluigi Paggiaro, MD

Italy

Full Professor of Respiratory Medicine at the University of Pisa from 2007 to 2018 and Chief of the Respiratory Pathophysiology and Pulmonary Rehabilitation Unit of the University Hospital of Pisa. Graduated in Medicine and Surgery at the University of Pisa in 1972, He post-graduated in Occupational Medicine (1974), Respiratory Medicine (1977) and Allergy and Clinical Immunology (1981). Post-doctoral fellowships at the University of British Columbia (Vancouver, Canada, 1985 and 1987) and at the S. Francisco General Hospital (S. Francisco, Ca, USA, 1989).

The research fields include: pathophysiology and therapy of asthma and COPD, occupational asthma, airway pharmacology, pulmonary rehabilitation, COPD and bronchiectasis. He was the Principal Investigator of several phase 2-phase 3 clinical trials in asthma and COPD, and Principal Investigator of several research projects funded by Italian Ministry of Health, Italian Agency of the Drug (AIFA), Tuscany Region and pharmaceutical companies. He is component of the Steering Committee of the Italian Network on Severe Asthma (SANI) and of the Steering Italian Committee of the Precision International Project.

From 2005 to 2014, He was member of the Board of Directors of GINA International, and Chairman of the GINA Mediterranean Initiative. Since 2005 He is the chairmen of the GINA Italy Initiative. In 2016 He was nominated as Fellow of European Respiratory Society

He is author or co-authors of more than 330 manuscripts published on peer-review international journals (see PubMed) on asthma, COPD and bronchiectasis.

Hatoon Bakhribah, MD

Riyadh, Saudi Arabia

Consultant, Medical Oncology
King Fahad Medical City
Comprehensive Cancer Center

Ali AlBarrak, FRCPC, FACP

Riyadh, Saudi Arabia

Consultant, Internal Medicine & Infectious Diseases
Prince Sultan Military Medical City

Waleed Saleh, MBBS, FRCS (IRELAND)

Riyadh, Saudi Arabia

Associate Professor (Adj.)
College of Medicine, Alfaisal University
Consultant Thoracic Surgery
Section Head Thoracic and Lung Transplant Surgery
King Faisal Specialist Hospital & Research Centre

Khaled M. Al Kattan, MD, FRCS

Riyadh, Saudi Arabia

Professor and Consultant Thoracic Surgery
King Faisal Specialist Hospital & Research Centre
Dean, College of Medicine
Alfaisal University

Ahmed Alshehri, ABIM, FRCPC, MMEdu

Jeddah, Saudi Arabia

Assistant Professor of Internal Medicine
King Saud University for Health Sciences
Consultant Medical Oncologist
King Abdulaziz Medical City

Sami Alhaider MD, MSc, MBA

Riyadh, Saudi Arabia

Associate Professor of Pediatrics (Adj.)
College of Medicine, Alfaisal University
Consultant Pediatric Respirologist and
Interventional Pulmonologist
Department of Pediatrics
King Faisal Specialist Hospital & Research Center

Riyad Al-Lehebi, MD, FRCPC, DABIM

Riyadh, Saudi Arabia

Assistant Professor of Medicine (Adj.)
College of Medicine, Alfaisal University
Consultant, Pulmonary Medicine
Asthma and Sleep Medicine
King Fahad Medical City

Hussam Adi, MD, MMAS(UK), FACS, FASMBS

Tabuk, Saudi Arabia

Consultant Laparoscopic Surgeon
Director, Resident Training Program
Head, Advanced Laparoscopic & Bariatric Surgery Center
King Salman Armed Forces Hospital

Waseem Hajjar, MD. MS, FRCS, FCCP

Riyadh, Saudi Arabia

Professor and Consultant Thoracic Surgeon
Deputy Head, Division of Thoracic Surgery
Department of Surgery
Associate Director, Thoracic Surgery Fellowship Program
King Saud University Medical City

Khalid F. Al-Mobaireek

Riyadh, Saudi Arabia

Associate Professor of Pediatrics
Consultant, Pediatric Pulmonologist
King Saud University Medical City

Faris Alhejaili, MD, MS

Jeddah, Saudi Arabia

Associate Professor of Medicine
Consultant Pulmonary and Sleep Medicine
Department of Medicine
King Abdulaziz University

Prof. Mark Metersky, MD, FCCP

USA

Dr. Mark L. Metersky, MD, FCCP is a Professor of Medicine at the University of Connecticut School of Medicine where he serves as the Chief of Service for the Department of Medicine, Chief of the Division of Pulmonary, Critical Care and Sleep Medicine and Director of UCONN Center for Bronchiectasis Care.

He is a graduate of the New York University School of Medicine, then went on to train in Internal Medicine at Boston City Hospital and then in Pulmonary and Critical Medicine at the University of California, San Diego Medical Center.

Dr. Metersky has long standing interest in pulmonary infections, including pneumonia and bronchiectasis and has over 150 publications and has presented extensively on these subjects. He serves as the Chair of the COPD Foundation-sponsored United States Bronchiectasis and NTM Research Registry.

He serves as an ad hoc reviewer for over 20 journals, and is on the Editorial Board of CHEST. He was the American Thoracic Society Co-Chair of the writing panel for the “Management of Adults with Hospital-acquired and Ventilator-associated Pneumonia: 2016 Clinical Practice Guidelines by the Infectious Diseases Society of America and the American Thoracic Society” and was a co-author of the 2019 ATS/IDSA Community-Acquired Pneumonia Guidelines.

Dr. Catherine L. Oberg, MD, DAABIP

USA

Dr. Catherine Oberg is an Interventional Pulmonologist in Los Angeles, California. She completed medical school at the University of Tennessee (her home state), residency training in Internal Medicine at the University of Southern California (USC) in Los Angeles, Pulmonary/Critical Care fellowship training at the Icahn School of Medicine at Mount Sinai in New York City, NY, and Interventional Pulmonology advanced fellowship training at the Harvard Combined Program (Beth Israel Deaconess Medical Center/Massachusetts General Hospital) in Boston. She has since been in practice at the University of California, Los Angeles (UCLA) where she is the Director of Interventional Pulmonology, South Bay, and the Program Director for the Interventional Pulmonology fellowship.

She is interested in advancing Interventional Pulmonology clinical practice through research and education. She routinely gives regional, national, and international lectures on robotic/navigational bronchoscopy, complex airway disease, pleural disease, and esophageal procedures. She has also published multiple peer-reviewed articles and book chapters on various topics related to IP. She is a reviewer for multiple medical journals and has been voted as a Top Reviewer for the Annals of Internal Medicine three years in a row. She was also voted as a Super Doctor, Rising Star for 2022 and 2023.

She is an avid traveler and has visited over 30 countries. She enjoys medical volunteer work which she has done in Tanzania, India, and Haiti as well as in her local communities in Memphis, New York, and Los Angeles. She is honored to be a part of the Saudi Thoracic Society 2023 International Conference!

Prof. Leonardo M. Fabbri, MD, FERS, FCCP

Italy

Leonardo M. Fabbri was Professor and Director of Internal Medicine and of Respiratory Medicine at the University of Modena and Reggio Emilia until 2016. Then he became and still is Eminent Scholar of Respiratory and Internal Medicine at the University of Ferrara. He served as Associate Editor in some of the most important Respiratory Journals (AJRCCM, Lancet Resp Med, Eur Respir J), and continues to serve as reviewers for the same journals and journals of internal medicine.

He was one of the founding partners of the Global Initiative on Asthma (GINA) and Global Initiative on Obstructive Lung Disease (GOLD). He was President of the European Respiratory Society (ERS) (2007-2008).

His main areas of interest have been and still are asthma, COPD and chronic multimorbidity. He has published > 600 papers in peer reviewed journals plus several book chapters. His Hirsh Index March 2023 are 127 according to Google Scholar and 107 according to Scopus.

Prof. John W. Hanrahan, PhD

Canada

Dr. Hanrahan received his PhD from the University of British Columbia and completed post-doctoral studies at Yale Univ. Sch. Medicine from supported by fellowships from NSERC/NATO and the Medical Research Council of Canada. At Yale he carried out noise analysis and patch clamp studies of anion channels in the rabbit urinary bladder epithelium. In 1986 he was recruited to the Department of Physiology at McGill University where he was supported as an FRQS Chercheur Boursier, and by MRC Scholar, Scientist and Senior Scientist awards.

He is currently professor of Physiology, founding director of the Cystic Fibrosis Translational Research centre (CFTRc), and associate member of the Meakins-Christie Laboratories and the Research Institute of the McGill University Health Centre. He is co-founder of Traffick Therapeutics, a Montreal-based spin-off company. He has extensive international collaborations and recently completed an E-rare project (INSTINCT) with groups in Germany, Italy, The Netherlands, Portugal and Canada.

He currently serves on a scientific advisory board for a Strategic Research Centre sponsored by the UK CF Trust. After establishing a laboratory at McGill, Dr. Hanrahan helped to identify the anion channel that is defective in cystic fibrosis (CF), which was subsequently named CFTR, and helped establish that the defective gene encodes that channel. He studied its permeation properties, regulation of CFTR by kinases and phosphatases, and demonstrated that it is initially stimulated and then inhibited by exposure to cigarette smoke. His laboratory is currently focused on understanding acquired CFTR deficiency in COPD, the role of pulmonary ionocytes in pH and bicarbonate regulation on the airway surface, and delivery of therapeutics to the lungs using novel polymeric nanoparticles.

Prof. Burton F. Dickey, MD

USA

Dr. Dickey is a Professor of Pulmonary Medicine at the University of Texas MD Anderson Cancer Center, where he was Department Chair from 2001-2021.

His clinical practice is focused on diseases of the airways, including asthma, bronchiectasis complicating immune deficiency, and obliterative bronchiolitis complicating hematopoietic transplantation.

He has operated a research laboratory since 1986 focused on epithelial innate defenses. These include inducible resistance to microbial infection and the production and secretion of airway mucins. He has more than 170 publications in PubMed (with >13,000 citations in Google Scholar, h-index 61).

Prof. Elena Bargagli, MD, PhD

Italy

Elena Bargagli, MD, PhD, is Full Professor of Respiratory Medicine at the University Hospital Policlinic of Siena. She is coordinator of Regional Referral Centre for Rare Lung Diseases and Lung Transplantation. She is Director of the Graduate School of Respiratory Medicine of the University of Siena.

Dr Bargagli specialized in pulmonary diseases at the University of Siena where she received her medical degree. She obtained a Research Doctorate Degree at the University of Siena. She is the coordinator of ERS Assembly 12.02 for Interstitial Lung Diseases of known causes.

Her research interests include the study of sarcoidosis and ILD pathogenesis, the identification of novel biomarkers of ILD and lung transplantation in serum, BAL and lung tissue, the omic approaches to the study of respiratory diseases.

Dr. Erik Folch, MD, MSc

USA

Dr. Folch was born and raised in Mexico City. He received his medical degree from Universidad Nacional Autonoma de Mexico, and Masters of Science in Clinical Research from Emory University. He trained in Internal Medicine at Emory University, and Pulmonary, Critical Care, Interventional Pulmonary at Cleveland Clinic.

He is currently the Chief of the Complex Chest Disease Center and Co-Director of IP at Massachusetts General Hospital, Harvard Medical School and has authored over 100 peer-reviewed articles. He has experience in designing clinical trials and has let multi-center clinical trials in advanced bronchoscopy.

He is an authority in robotic bronchoscopy and has participated of the initial trials in peripheral ablation of lung cancer.

Prof. Jordi Rello, MD, PhD

Spain

Dr. Jordi Rello earned with honours his Medical Degree (1985) and PhD in Infectious Diseases (1990) at University of Barcelona, Spain, completing a residence/fellowship in Critical Care (1990) in Hospital Sant Pau in Barcelona. Dr Rello get additional training in infection control and ID epidemiology at Harvard Medical School, Boston.

Currently, he is Full Professor of Medicine at Universitat Internacional de Catalunya, Barcelona, Spain and Director of the Clinical Research/Innovation in Pneumonia and Sepsis (CRIPS) Group at Vall d’Hebron Research Institute & CIBERES, ubicated in Vall d’Hebron Barcelona Hospital Campus.

He has conducted clinical practice as consultant, leaded research and trained fellows in critical care from 1990, with special focus on severe pneumonia & precision medicine in sepsis. After serving as critical care consultant in Hospital Clinic de Barcelona & Hospital Tauli in Sabadell, Dr Rello become Head of the ICU Department in 1999 in the University Hospital de Tarragona and in 2000 at the University Hospital Vall d’Hebron, Barcelona.

He has directed above 20 doctoral thesis, being part of his academic duties as Professor of Medicine at the Universitat Autònoma de Barcelona and Rovira & Virgili University in Tarragona.

Prof. Rello has > 630 indexed manuscripts with above 50,000 citations (overall 2,850 per year from 2013), an H-index of 117.

Prof. Darcy D. Marciniuk MD, FRCPC, FCAHS, Master FCCP

Canada

Dr. Marciniuk is recognized internationally as an expert and leader in COPD, clinical exercise physiology and Pulmonary Rehabilitation, with more than 460 invited national and international presentations and 245 peer-reviewed publications.

Darcy led three CTS COPD practice guidelines, and recently chaired a multi-society international guideline on the effect of race on pulmonary function testing. He has also participated in numerous international guidelines for COPD, cardiopulmonary exercise testing, Pulmonary Rehabilitation, and prevention of acute exacerbations of COPD.

Dr. Marciniuk is the Medical Director of the LiveWell COPD Program in the Saskatchewan Health Authority and serves as Deputy Editor Outreach for the journal CHEST. Dr. Marciniuk is a past-President of the Canadian Thoracic Society and American College of Chest Physicians, served as Chair of the Forum of International Respiratory Societies, and is a Fellow of the Canadian Academy of Health Sciences.

Hussam Sakkijha, MD

Riyadh, Saudi Arabia

Consultant, Pulmonary, Critical Care and Sleep Medicine
King Fahad Medical City

Hani Lababidi, MD, FCCP, FACP, FSSH

Riyadh, Saudi Arabia

Consultant, Pulmonary and Critical Care Medicine
Vice President, Saudi Society for Simulation in Healthcare
King Fahad Medical City

Ahmed Jamjoom, MD

Jeddah, Saudi Arabia

Consultant, Cardiothoracic Surgery
Chairman, Cardiovascular Disease Department
King Faisal Specialist Hospital & Research Center

Mohamed S. Al-Hajjaj, MD, FRCP(C)

Sharjah, UAE

Professor and Senior Consultant Pulmonary Medicine
Vice-President, Saudi Thoracic Society
Chairman, Clinical Sciences Department
College of Medicine, University of Sharjah, UAE

Fahad A. Almugbel, MBBS

Riyadh, Saudi Arabia

Consultant, Medical Oncologist
King Faisal Specialist Hospital & Research Center

Fahad Ibnshamsah, MD

Dammam, Saudi Arabia

Assistant Professor of Medicine
Imam Abdulrahman Bin Faisal University
Consultant, Adult Medical Oncology
Executive Director, Oncology Center of Excellence
Director, Outreach program
King Fahad Specialist Hospital

Waleed Alselwi, MD

Dammam, Saudi Arabia

Consultant, Adult Medical Oncologist
Program Director, Adult Medical Oncology Fellowship Program
King Fahad Specialist Hospital

Abdulraheem Alshangiti, MD

Dammam, Saudi Arabia

Consultant, Adult Medical Oncologist
Chairman, Adult Medical Oncology
King Fahad Specialist Hospital

Abdullah A. Al-Sharm, MD

Riyadh, Saudi Arabia

Consultant, Medical Oncology
Director of Comprehensive Cancer Center
Assistant Professor of Medicine
King Saud bin Abdul-Aziz University for Health Sciences
King Fahad Medical City

Ahmed Alwbari, MD

Dammam, Saudi Arabia

Assistant professor of Medicine
Consultant hematology and Oncology
King Fahad Specialist Hospital

Ahmed A. Aljohaney, MBBS, DABIM, FRCPC

Jeddah, Saudi Arabia

Ahmed Abdulaziz Aljohaney, MBBS, DABIM, FRCPC-1

Professor of Medicine
King Abdulaziz University
Consultant, Pulmonary Medicine
Interventional Pulmonology
Head of Bronchoscopy Unit
King Abdulaziz University Hospital

Esam M. Murshid, MD, MSc, MBA, FRCR

Riyadh, Saudi Arabia

Consultant, Medical Oncologist
Breast and Gu Oncologist
Director Oncology Department
Prince Sultan Medical Military City

Kanaan Al Shammari, MD

Riyadh, Saudi Arabia

Assistant Professor of Medicine
king Saud bin Abdulaziz University for Health Sciences
Consultant, Adult Medical Oncologist
King Abdulaziz Medical City
Ministry of National Guard Health Affairs

Mohammed A. Algarni, MD

Riyadh, Saudi Arabia

Assistant Professor of Medicine (Adj.)
king Saud bin Abdulaziz University for Health Sciences
Consultant, Medical Oncologist
Department of Oncology
King Abdulaziz Medical City
Ministry of National Guard Health affairs

Waleed A. Alghareeb, MD

Riyadh, Saudi Arabia

Consultant, Medical Oncologist
King Fahad Medical City

Ali Aljubran, MD

Riyadh, Saudi Arabia

Professor of Medicine (adj.)
College of Medicine, Alfaisal University
Consultant, Medical Oncology
King Faisal Specialist Hospital & Research Center

Mohammed Alghamdi, MD

Riyadh, Saudi Arabia

Consultant, Adult Medical Oncologist
Deputy Director of the Oncology Center
Head of the Medical Oncology Unit
King Saud University Medical City

Shouki Bazarbashi, MBBS

Riyadh, Saudi Arabia

Professor of Medicine (Adj.)
College of Medicine, Alfaisal University
Acting Director, Oncology Center
Chairman, Research Ethics Committee
King Faisal Specialist Hospital & Research Center

Majed Alghamdi, MD

Riyadh, Saudi Arabia

Assistant Professor of Medicine
College of Medicine
King Saud Bin Abdulaziz University for Health sciences
Consultant Pulmonologist
King Abdulaziz Medical City

Safwan A. Bakhsh, MBBCh, ABIM, FRCPC

Jeddah, Saudi Arabia

Consultant, Medical Oncologist
King Faisal Specialist Hospital & Research Centre

Fadi S. Aljamaan, MD

Riyadh, Saudi Arabia

Assistant Professor of Medicine
King Khalid University Hospital
King Saud University
Consultant, Critical Care Medicine
Critical Care Department
King Saud University Medical City

Abdullah Alshimemeri, MD

Riyadh, Saudi Arabia

Professor of Medicine
Consultant, Pulmonary and Critical Care Medicine
AlmisharI Hospital

Mohamed Zeitouni, MD, FCCP

Riyadh, Saudi Arabia

Consultant Pulmonary/Critical Care Medicine
Department of Medicine
King Faisal Specialist Hospital & Research Centre

Muhannad Hawari, MD

Riyadh, Saudi Arabia

Assistant Professor of Medicine (Adj.)
College of Medicine, Alfaisal University
Consultant Pulmonary Medicine
Director, Sleep Medicine
Department of Medicine
King Faisal Specialist Hospital & Research Center

Mervat Mahrous, MD

Riyadh, Saudi Arabia

Assistant Professor of Oncology
Faculty of Medicine Minia University
Consultant Medical Oncology
Adult Medical Oncology Department
Prince Sultan Military Medical City

Mohammed Alhajji, MD, MSc, FRCP (London)

Riyadh, Saudi Arabia

Consultant Pulmonary Medicine
Interventional Pulmonology
Department of Medicine
King Faisal Specialist Hospital &Research Center

Ahmed Refae, MBBCh, MSc, MD

Jeddah, Saudi Arabia

Associate Professor, Clinical Oncology
Ain Shams University, Cairo, Egypt
Consultant Clinical Oncology
International Medical Center Jeddah

Ahmed S. Al Enezi, MD

Riyadh, Saudi Arabia

Consultant Pediatric Pulmonary and Sleep Medicine
Executive Director of Riyadh Health Zone, R1
Chief Executive Officer
King Saud Medical City

Bader J. Alghamdi, MD

Jeddah, Saudi Arabia

Consultant Pulmonary Medicine
Assistant Professor (adj.)
Division Head of Respirology
Director, Pulmonary Fellowship Training Program-WR
King Abdulaziz Medical City

Marwan Al Hejili, MD

Jeddah, Saudi Arabia

Associate Professor of Medicine
Consultant Hematology and Oncology
Head, Oncology Division
Head, Clinical Trials Unit
King Abdulaziz University

Ameen S. Al-Omair, MD, FRCPC

Riyadh, Saudi Arabia

Consultant Radiation Oncologist
Oncology Centre
King Faisal Specialist Hospital & Research Centre

Waleed A. AlSowayan, MD

Riyadh, Saudi Arabia

Consultant Pulmonary Medicine
Pulmonary Rehabilitation
Head, Pulmonary Division
Director, Pulmonary Fellowship Program
Security Forces Hospital Program

Abdullah K. Altwairgi, MD

Riyadh, Saudi Arabia

Consultant, Medical Oncology
Comprehensive Cancer Center
King Fahad Medical City

Adel S. Alharbi, MD, FCCP

Riyadh, Saudi Arabia

Professor of Pediatrics (Adj.)
College of Medicine, Alfasial University
General Secretary, Saudi Thoracic Society
Chairman, Saudi Pediatric Pulmonology Association
Associate Editor, Annals of Thoracic Medicine
Associate Editor, Saudi Medical Journal
Consultant, Pediatric Pulmonologist & Sleep Physician
Director, Pediatric Sleep Disorders Center
Deputy Executive Director for Academic Affairs
Prince Sultan Military Medical City, Ministry of Defense

Ashwaq B. Alshareif, MD

Riyadh, Saudi Arabia

Consultant Pulmonary Medicine
Adult Cystic Fibrosis and Bronchiectasis
King Fahad Medical City

Shadi S. Alkhayyat, MD

Jeddah, Saudi Arabia

Associate professor of Medicine and Oncology
Medical Director, King Abdulaziz University
Chairman, Emergency Department
King Abdulaziz University Hospital

Enas Mansour Batubara, MD, SB-IM, SF-AP, FCCP

Riyadh, Saudi Arabia

Consultant, Pulmonary Medicine
Interventional Pulmonology
Head, Division Pulmonary Medicine
Prince Sultan Military Medical City

Abdullah F. Al-Mobeireek, FRCP, FCCP

Riyadh, Saudi Arabia

Professor of Medicine
Consultant, Pulmonary Medicine
Department of Medicine
King Faisal Specialist Hospital & Research Center

Muath A. ALNassar, MD

Kuwait City, Kuwait

Consultant Medical Oncologist
Head of Thoracic/Head and neck/ Sarcoma Unit
Kuwait Cancer Control Center

Hamdan Al-Jahdali, MD, FRCPC, FCCP

Riyadh, Saudi Arabia

Professor and Consultant Pulmonary Medicine
King Saud University for Health Sciences
Professor- McGill University (Adj.)
Head, Pulmonary Division,
Director, Sleep Disorders Center
King Abdulaziz Medical City
Ministry of National Guard Health Affairs

Prof. Anke-Hilse Maitland-van der Zee MSc, PharmD, PhD

Netherlands

Prof Dr Anke-Hilse Maitland-van der Zee is a Professor of Precision Medicine in the field of respiratory disease at the Amsterdam University Medical Centre, University of Amsterdam. She leads a group of 40 researchers performing research in both paediatric and adult respiratory diseases.

She received her master’s and PharmD in pharmaceutical sciences at the University of Groningen, and completed her PhD at the department of pharmacoepidemiology and clinical pharmacology at Utrecht University. She completed her post-doctoral research at the Human Genetics Center, University of Texas, Houston.

Prof Dr Maitland-van der Zee has published > 300 articles in peer reviewed journals and was the co-ordinator of many international research projects. Prof Dr Maitland-van der Zee is currently the president of the Dutch Federation of Innovative Drug Research (FIGON).

Shareefah M. Basheri, MD

Riyadh, Saudi Arabia

Consultant, Pulmonary Medicine
Pulmonary Rehabilitation and Chronic Ventilation
Director, Internal Medicine Residency Training Program
Assistant professor of Medicine (Adj.)
College of Medicine, Alfaisal University
Prince Sultan Military Medical City

Mohammed Al Ghobain, MD, MPH

Riyadh, Saudi Arabia

Professor of Pulmonary Medicine
Consultant, Pulmonary Medicine
King Abdulaziz Medical City
Ministry of National Guard Health Affairs

Nuha Alrajhi, MBBS, SB-MED, ABIM, KSUF-MED

Riyadh, Saudi Arabia

Assistant Professor of Medicine
Consultant, Pulmonary Medicine
Interstitial Lung Disease
King Saud University Medical City

Nizar M, Yamani, MBBS

Riyadh, Saudi Arabia

Assistant Professor of Surgery
Consultant, Thoracic and General Surgery
King Abdulaziz Medical City
Ministry of National Guard Health Affairs

Ranya A Alshumrani, MBBS, FAAP, FAASM

Jeddah, Saudi Arabia

Assistant professor
Division of Pulmonary and Sleep Medicine
Department of Pediatric
King Abdul Aziz university

Medhat M. Bukhari, MB&ChB FRCSC

Dhahran, Saudi Arabia

Consultant, Thoracic Surgeon
Johns Hopkins Aramco Healthcare

Majdy Idrees, MD, FRCPC, FCCP, FPVRI, FRCP Edin (Hon)

Riyadh, Saudi Arabia

Professor of Pulmonary Medicine (Adj.)
University of British Columbia, Vancouver, Canada
Pulmonary Medicine
Pulmonary Vascular Unit
Prince Sultan Military Medical City

Turki S. Alahmadi, MD

Jeddah, Saudi Arabia

Associate Professor of Pediatrics
Division of Pulmonary Medicine
Chairman, Pediatric Department
Faculty of Medicine – Rabigh
King Abdulaziz University

Ahmed Almotiri, MD, RRT

Riyadh, Saudi Arabia

Consultant Pulmonary and Sleep Medicine
Division of Pulmonary Medicine
Department of Medicine
King Abdulaziz Medical City

Siraj O. Wali, MBBS, FRCPC, FACP, FCCP

Jeddah, Saudi Arabia

Professor of Pulmonary and Sleep Medicine
College of Medicine, King Abdulaziz University
Director, Sleep Medicine and Research Center
King Abdulaziz University Hospital

Turki Al Faye, MD, ABIM, FRCPC

Jeddah, Saudi Arabia

Assistant Professor of Medicine
Consultant, Medical Oncology
Princess Noora Oncology Center
King Abdulaziz Medical City
King Saud Bin Abdulaziz University for Health Science

Hamed Al Husaini, MD

Riyadh, Saudi Arabia

Assistant Professor (adj.)
College of Medicine, Alfasial University
Consultant, Medical Oncology
King Faisal Specialist Hospital and Research Center

Tarek Kashour, MD, FRCPC, FACC

Riyadh, Saudi Arabia

Professor of Medicine
Consultant, Adult Cardiology
Head, CHD Taskforce, SAPH
King Fahad Cardiac Center
King Saud University Medical City

Samah Alrehaily, MD

Jeddah, Saudi Arabia

Consultant, Medical Oncologist
Princess Noorah Oncology Center
King Abdulaziz Medical City

Saleh N. Abu-Daff, MBBS. MRCS-UK

Riyadh, Saudi Arabia

Consultant, General Thoracic Surgery
King Fahad Medical City
Ministry of Health

Suha K. Kaaki, MBBS, FRCSC, FACS

Riyadh, Saudi Arabia

Assistant Professor of Surgery
Thoracic and Foregut Surgeon at King Saud University Medical City
Program Director, Thoracic Surgery Fellowship
King Saud University

Yaseen Arabi, MD, FCCP, FCCM, ATSF

Riyadh, Saudi Arabia

Professor, College of Medicine
King Saud Bin Abdulaziz University for Health Sciences
Professor (adj.), Monash University, Melbourne, Australia
Chairman, Intensive Care Department
Medical Director, Respiratory Services
King Abdulaziz Medical City

Mohamed S. Al-Moamary, ABIM, FRCP(Edin), MBA-LS, FCCP

Riyadh, Saudi Arabia

Professor and Consultant Pulmonary Medicine
Chairman, Saudi Initiative for Asthma
Editor-in-Chief, Annals of Thoracic Medicine
King Abdulaziz Medical City
Ministry of National Guard Health Affairs

Hatem O. Qutub, MD, FCCP, FCCM

Alkhobar, Saudi Arabia

Professor of Medicine
Division Head, Pulmonary Medicine
Senior Consultant Intensivist, Pulmonologist
Department of Medicine – KFHU
Al Imam Abdulrahman Bin Faisal University

Ahmed Allehebi, MBBS, FRCPC

Jeddah, Saudi Arabia

Chairman, Oncology Summit
Chairman, Saudi Lung Cancer Association
Consultant, Medical Oncology
King Faisal Specialist Hospital & Research Center

Esam H. Alhamad, MD, FACP

Riyadh, Saudi Arabia

Professor of Medicine
President, Saudi Thoracic Society
Chairman, STS 2023 International Conference
Director, ILD & PH center
Director, Interstitial Lung Disease Fellowship Program
King Saud University Medical City

Prof. Pamela J. McShane, MD

USA

Dr. Pamela McShane was born and raised in Chicago. She attended Loyola University of Chicago for her undergraduate studies in Biology and went on to attend Loyola University Stritch School of Medicine. During fellowship training in pulmonary and critical care medicine at the University of Chicago, Dr. McShane developed a clinical and research interest in bronchiectasis and nontuberculous mycobacteria (NTM) lung disease.

She developed a Chicago based clinical and research registry for bronchiectasis patients and later joined the U.S. Bronchiectasis and NTM Research Registry. Dr. McShane went on to work at the U.S. National Institutes of Health in Bethesda, Maryland where she focused on NTM infection in bronchiectasis patients. In 2020, Dr. McShane moved to the University of Texas Health Science Center in Tyler, Texas which houses a world-renowned acid-fast bacteria laboratory.

She is medical director of the Bronchiectasis and NTM Pulmonary Institute at the University of Texas Health Science Center at Tyler. She is primary investigator for approximately a dozen clinic trials and she also serves as associate editor for CHEST and the Journal of Clinical Tuberculosis and Other Mycobacteria.

Prof. Carmine Dario Vizza, MD

Italy

Carmine Dario Vizza, MD, is Full Professor in Cardiology at the University of Rome La Sapienza, and Director of the Cardiologic Department of the Policlinico Umberto I University Hospital.
He is the founder and past-president of the Italian Pulmonary Hypertension Network (IPHNET) which includes 28 italian PH centers.

Professor Vizza has a large clinical experience in the treatment of pulmonary hypertension, he published widely in the field of pulmonary vascular physiology, right ventricular function in pulmonary hypertension, risk stratification in PAH, and pulmonary transplantation. He participated as principal investigator to several international multicenter randomized study on pulmonary hypertension. He served as a member of the steering committee of the COMPERA registry, PHORA.

Dr. Elliot Ho, DO

USA

Dr. Elliot Ho completed his Internal Medicine residency training at the University of California Los Angeles – Olive View, and his Pulmonary and Critical Care Medicine fellowship training at the University of California San Francisco – Fresno. He pursued further sub-specialty training in Interventional Pulmonology at the University of Chicago.

He is currently Assistant Professor at Loma Linda University in Loma Linda, California. His research experience has included the use of thoracic ultrasound, robotic bronchoscopy, and endobronchial ultrasound. With over 10 publications, Dr. Ho plans to continue pursuing his research interest in
navigational bronchoscopy and pleural disease. He hopes to expand the accessibility of minimally invasive bronchoscopic techniques in robotic bronchoscopy and bronchial lung volume reduction for emphysema.

Prof. Demosthenes Bouros, MD, PhD, FERS, FAPSR, FCCP

Greece

Dr. Demosthenes Bouros is emeritus professor of Pneumonology at the National and Kapodistrian University of Athens, Medical School, Greece. He started his academic career as assistant Professor of Pneumonology (1989) and associate Professor (1995-2002), at the Medical School, University of Crete, and Professor of Pneumonology at the Democritus University of Thrace, Greece (2002-2014), and Professor of Pneumonology at the National and Kapodistrian University of Athens, Greece (2014-2019). He was trained at Harvard and Boston Universities, USA, and the Royal Brompton Hospital, UK. He warded as visiting professor at the Medical University of Vienna by the European Respiratory Society (ERS).

Clinical Experience: Since 2019 is head of the department of respiratory diseases and the ILDU unit of the Athens Medical Center, Athens, Greece. Previous posts: head of Respiratory disease departments: 401 Army General Hospital, Athens (1984-1986 and 1988-1990); vice director Dept. of Thoracic Medicine, University hospital of Crete (1990-2002); director Dept. of Respiratory Medicine, University hospital of Alexandroupolis (2002-2014); head of ILD unit, Hospital for Diseases of the Chest ‘Sotiria”, Athens, (2014-2019), which is the National center of excellence for rare pulmonary diseases with >2000 patients in record, participating in many international clinical trials.

As an international expert in interstitial lung diseases, he served as a Member of the ATS/ERS/JRS/ALAT committee for the idiopathic pulmonary fibrosis (IPF) official guidelines (AJRCCM 2011, AJRCCM 2018, AJRCCM 2021) guidelines; he served also as a member of the ATS/ERS new classification of idiopathic interstitial pneumonias (IIPs) (AJRCCM 2013).

His main research interests include the pathophysiologic/pathogenetic mechanisms, clinical presentation, and course of interstitial lung diseases. Among them is the investigation of experimental pharmacologic treatments for ILDs and their comorbidities, the role of the mesenchymal stem cell and extracellular vesicles application in chronic lung diseases, including pulmonary fibrosis and COPD.

Dr. Roberto Tonelli, MD, PhD

Italy

Dr. Roberto Tonelli, MD, PhD, works as Assistant Professor in Respiratory Medicine in the Respiratory Intensive Care Unit of the University Hospital of Modena. He had training periods at the Respiratory Disease Unit of the Royal Brompton Hospital of London (UK), at the Interstitial Lung Disease Unit of the University of California San Francisco of San Francisco (CA, USA) and at the Intensive Care Unit of the Amsterdam University Medical Centers (NL)

During his career, he has been developing skills in the management of acute respiratory failure requiring non-invasive respiratory support and mechanical ventilation. His research activities mainly focused on respiratory mechanics and patient’s self-inflicted lung injury during non-assisted and assisted spontaneous breathing in patients with acute hypoxic respiratory failure (AHRF). Moreover, he has been spending great interest in the monitoring of patients with AHRF with the aim to identify early predictors of ventilatory failure. He also explored the mechanical properties of the fibrotic lung during, controlled, assisted and non-assisted spontaneous breathing. Since 2023 he holds the patent N 102021000007478 for the “Apparatus for detecting and monitoring of nasal pressure” released by the Italian Ministry of Enterprises and Made in Italy and he is co-founder of the start-up IREC ltd. He co-founded the Experimental Pulmonology Laboratory of the University of Modena and Reggio Emilia. He is member of the European Respiratory Society and the Italian Society of Pulmonology.

He is currently involved in the design and conduction as PI and co-PI of several clinical trials exploring respiratory mechanics in patients with acute respiratory failure. Roberto Tonelli has published more than 90 peer reviewed papers and serves as associate editor, guest editor and reviewer for several major journals on respiratory diseases.

Dr. Stephen C Mathai, MD, MHS, FCCP

USA

Dr. Stephen C. Mathai, MD, MHS is an Associate Professor of Medicine and part of the Johns Hopkins Pulmonary Hypertension Program. A graduate of Jefferson Medical College, he pursued residency training at Thomas Jefferson University Hospital, where he also served as Chief Medical Resident. During his 5-year fellowship in Pulmonary and Critical Care Medicine at Johns Hopkins University, he obtained a Masters of Health Science degree from the Johns Hopkins Bloomberg School of Public Health. Subsequently, he received a K23 award for his research in pulmonary vascular disease in scleroderma.

He currently serves as Co-Principal Investigator for the Johns Hopkins PVDOMICS program supported by the NIH and is principal investigator for a clinical trial of therapy for scleroderma associated pulmonary hypertension supported by the Department of Defense Peer Reviewed Medical Research Program. He is also the Co-Director of the Ann Dana Kusch Multidisciplinary Program for Interstitial Lung Disease and Pulmonary Hypertension.

Dr. Mathai is a Fellow of the American College of Chest Physicians. He has been active in numerous committees and holds several leadership positions in academic societies. He currently serves on the Scientific Secretariat for the World Symposium on Pulmonary Hypertension. Dr. Mathai is a former member of the Scientific Leadership Council of the Pulmonary Hypertension Association and also served on the Rare Disease Advisory Panel for the Patient Centered Outcomes Research Institute (PCORI). He is the past chair of the Pulmonary Vascular Disease Network for the American College of Chest Physicians. He has published over 125 original research articles, along with numerous editorials and book chapters.

Prof. Cori L Daines, MD

USA

Dr. Daines earned her doctorate at St. Louis University School of Medicine, completed her residency at Cardinal Glennon Children’s Hospital in St. Louis, and did her fellowship in pediatric pulmonary medicine at the University of North Carolina. She worked at Cincinnati Children’s Hospital Medical Center before joining The University of Arizona in 2007.

Dr. Daines is a Professor of Pediatrics, Division Chief Pediatric Pulmonary and Sleep Medicine, University of Arizona. She is director of the pediatric flexible bronchoscopy program and pediatric respiratory care for the Banner University Medical Center Tucson, and CF center director at the Tucson Cystic Fibrosis Care Center. She cares for children with chronic pulmonary disorders including asthma, cystic fibrosis, apnea and sleep disorders, neuromuscular diseases, airway disorders, and aerodigestive diseases. She is an expert in pediatric flexible bronchoscopy. She currently serves as President of the Pediatric Pulmonary Division Directors Association.

In addition to caring for children with pulmonary disorders, Dr. Daines conducts research through the Steele Children’s Research Center and the Asthma and Airway Diseases Research Center at the University of Arizona. She is director of the Clinical Trials Unit for the Asthma and Airway Diseases Research Center. She directs the University of Arizona’s Pediatric Pulmonary Center, a HRSA-funded training center grant to provide leadership in the care of children with complex pulmonary diseases. Her research interests include the pulmonary manifestations of gastrointestinal diseases and the impact of pulmonary aspiration on chronic lung disease. She also directs the University of Arizona’s Therapeutic Development Center for the Cystic Fibrosis Foundation and has funded clinical trial research, quality improvement research projects as well as funded adherence research projects in cystic fibrosis from the Cystic Fibrosis Foundation.

Dr. Daines is board certified by the American Board of Pediatrics and the American Board of Pediatric Pulmonology.

Prof. Christian Finley, MD, MPH, FRCSC

Canada

Dr. Christian Finley is a national leader in lung cancer management, policy, governance, standardization and benchmarking. At the Canadian Partnership Against Cancer, he has led the development of partnerships with national and provincial/territorial governments, national societies and cancer agencies to establish solution-oriented approaches to the management of complex systems of care. He is the Lung Cancer Lead at the International Benchmarking Partnership and is an advisor on lung cancer screening for the Canadian Task Force on Preventive Health Care and is the Clinical Lead for lung cancer screening in Ontario.

Dr. Finley is a strategic leader with extensive expertise in the Canadian and International context. He has a track record of sound analytical judgment, organizational governance, and building dynamic teams to tackle key issues. Dr. Finley co-founded and leads the national quality improvement project for Thoracic Surgery. As a thoracic surgeon at one of the busiest centres in Canada, Dr. Finley has led many initiatives that have won awards for quality and patient-centered care.

Recognizing a local need, Dr. Finley conceived and fundraised for the creation of a palliative suite for patients to die with dignity.

Dr. Finley has received over 7 million dollars in research funding, published over 50 papers, and has been invited for over 100 national and international presentations. He has received numerous awards, including a prestigious James IV international award supporting outstanding surgical leaders to promote the exchange of knowledge around the globe. He holds a Masters degree in Public Health from Harvard University, a Doctor of Medicine from University of British Columbia and a Bachelor of Applied Science from Queen’s University. He has been an admissions interviewer for Harvard University for over 8 years.

He is the proud father of three girls and an avid outdoorsman.

Prof. David M. Rapoport, MD

USA

David M. Rapoport, MD, is currently Professor of Medicine Director of Sleep Research in the Division of Pulmonary, Critical Care and Sleep Medicine at the Icahn School of Medicine at Mount Sinai.

Dr. Rapoport received an SB in Physics at MIT and an MD at the Albert Einstein College of Medicine. He did internship and residency training in Internal Medicine at Roosevelt Hospital and Pulmonary training at Bellevue Hospital and New York University. He was on the faculty at NYU from 1980 to 2015 and established and directed the Sleep Medicine Program at NYU. In 2016 he joined the faculty of the Icahn School of Medicine at Mt. Sinai.

Dr. Rapoport’s research interests center around pulmonary and sleep physiology. He has spent his career studying control of breathing and of the upper airway, the epidemiology, causes, consequences and treatments of sleep disordered breathing. He is a “gadgeteer” by nature and has been involved since its origin in the development of nasal CPAP, the main treatment modality for obstructive sleep apnea. He is responsible for modifications of CPAP delivery aimed at making it more accessible and improving quality of the treatment and comfort/compliance with its use. Since the onset of the Covid-19 pandemic he has worked with Fisher and Paykel Healthcare on studying the generation and transmission of respiratory particles, both during spontaneous respiration and as a result of therapy with aerosol generating procedures like nasal high flow and CPAP/bilevel.

Dr. Rapoport was the New York Cohort Principle Investigator of the Sleep Heart Health Study, a large multicenter NIH sponsored epidemiologic study that assessed the cardiovascular consequences of sleep disordered breathing and of the CATNAP study, which aimed to evaluate the benefits of CPAP in mild to moderate obstructive sleep apnea. He is part of PRIDE, an NIH sponsored program that helps train and mentor minority junior faculty in preparation for careers in academic research. He is Principal Investigator or co-Principal Investigator of several industry-sponsored studies involving sleep disordered breathing and other sleep disorders. He is the founder and president of the Foundation for Research in Sleep Disorders, a non-profit that supports research and training in sleep medicine.

Dr. Rapoport originated and was the director of the NYU Sleep Medicine Fellowship Training Program until 2010; he has trained many clinical and research fellows in Sleep Medicine. He is a member of the American Thoracic Society, the American Physiological Society, the American Academy of Sleep Medicine and the Sleep Research Society. He is peer reviewer for multiple medical journals.

Dr. Rapoport is (co-)author of over 140 publications in peer-reviewed, international journals and holds 41 US Patents.

Prof. Konstantinos Kostikas, MD, PhD, FCCP, FERS

Greece

Dr Konstantinos Kostikas is Professor of Respiratory Medicine and Head of the Respiratory Medicine Department of the University of Ioannina, Greece, and Professor of Respiratory Medicine at the Observational and Pragmatic Research Institute, Singapore. He was trained at the University of Athens Medical School and the Royal Brompton Hospital, London, and has worked in academia and the pharmaceutical industry in global medical affairs roles.

Dr Kostikas is a member of GOLD COPD Assembly. He has more than 260 publications in PubMed (with >9,500 citations in Google Scholar, h-index 53), focusing on COPD, severe asthma, and new technologies. He is the Editor in Chief of Pneumon Journal (www.pneumon.org), associate editor of COPD: Journal of Chronic Obstructive Pulmonary Disease, and member of the editorial board of American Journal of Respiratory and Critical Care Medicine, PLoS One, Diagnostics and Frontiers in Medicine.

Dr. Paolo Spagnolo, MD, PhD

Italy

Paolo Spagnolo is an Associate Professor of Respiratory Medicine and Director of the Residency Program in Respiratory Medicine at the University of Padua (Italy). He received his undergraduate training and his MD, and completed his residency in Respiratory Medicine at the University Hospital of Bari (Italy). In 2002, Dr Spagnolo joined the Interstitial Lung Disease Unit (ILDU) of the Royal Brompton Hospital (London), initially as clinical research fellow under the supervision of Professor Ron du Bois and subsequently as Honorary Consultant. In 2008, he completed his PhD at the Imperial College of London under the supervision of Professor Ron du Bois and Professor Ken Welsh, with a thesis on “Genetic predisposition to clinical phenotypes of sarcoidosis”. Between 2008 and 2013, he was a research fellow and subsequently Assistant Professor in Respiratory Medicine at the University Hospital of Modena where he joined the Centre for Rare Lung Diseases led by Professor Luca Richeldi.

Since 2015, Dr Spagnolo is an Associate Professor of Respiratory Medicine at the Department of Cardiac, Thoracic, Vascular Sciences and Public Health of the University Hospital of Padua (Italy). His main research interests include ILD, mainly idiopathic pulmonary fibrosis (IPF), and sarcoidosis with emphasis on genetic predisposition, prediction of disease behaviour and clinical trials of novel therapies.

Dr Spagnolo is the author or co-author of over 150 journal articles, review articles and editorials. He is an Associate Editor for Chest. He is the Treasurer of the WASOG (World Association of Sarcoidosis and Other Granulomatous diseases) and Chair of the Study Group on Sarcoidosis and other Granulomatous ILD/DPLD of the European Respiratory Society. He is the chair of the European Reference Network (ERN) on rare lung diseases of the University Hospital of Padova (Italy).

Dr. John Goffin MD FRCPC

Canada

Dr. John Goffin is a medical oncologist at the Juravinski Cancer Centre at McMaster University in Hamilton, Canada. After completing his medical oncology training at McGill University, in Montreal, he undertook fellowships at the Canadian Cancer Trials Group in Kingston and the Dana-Farber Cancer Institute in Boston. He joined Tufts New England Medical Center in Boston in 2003.

In 2006, he returned to Hamilton as a thoracic and lower gastrointestinal oncologist and clinician educator. As an educator, Dr. Goffin developed a resident research curriculum to enhance resident understanding of research and to provide research opportunities.

Dr. Goffin’s research interests include finding the optimal implementation and cost-effectiveness of lung cancer screening. His interest in symptom control has led him to research the relationship between chronic obstructive lung disease and outcomes in lung cancer. He conducts clinical trials to improve cancer care and has studied how those trials may be conducted more efficiently and effectively.

Prof. Anjali Vaidya, MD, FACC, FASE, FACP

USA

Dr. Vaidya is Professor of Medicine and Co-Director of the Pulmonary Hypertension, Right Heart Failure, and CTEPH Program at Temple University School of Medicine. Since her recruitment to Temple in 2016, they have grown to be one of the largest PH, CTEPH, PTE, and BPA programs in the United States, and she has developed an international reputation speaking and educating in Pulmonary Hypertension and CTEPH. She serves as the founding Director of Temple’s Pulmonary Hypertension Fellowship, one of only a few in the nation, and Associate Program Director of the Cardiology Fellowship and Internal Medicine Residency Program.

She is the recipient of Temple Health System’s Educational Excellence Award for Educational Service, Educational Excellence Award for Graduate Medical Education, Mentoring Award for Women in Medicine and Science, and has been recognized as a Philadelphia Top Doctor for the last 5 years. She joined Temple after serving as Co-Director of PH and APD of the Internal Medicine Residency at the University of Pennsylvania, where she received the Donna McCurdy Department of Medicine Teaching Award. She has published over 50 academic articles and book chapters, and nearly 100 abstract presentations at Medical Symposia.

Prof. Marcos I. Restrepo, MD, MSc, PhD

USA

Dr. Marcos I. Restrepo, MD, MSc, PhD, FCCP, is a Professor at the Department of Medicine, Division of Pulmonary/Critical Care Medicine, at the University of Texas Health San Antonio (UTHSA). He is an investigator and staff physician at the South Texas Veterans Health Care System, Audie L Murphy Division. He is Medical Director of the Medical Intensive Care Unit at the South Texas Veterans Health Care System, Audie L Murphy Division and the Associate Program Director of the Pulmonary/Critical Care Medicine fellowship program at UTHSA.

Dr. Restrepo completed training and board certifications in internal medicine, infectious disease, pulmonary disease, and critical care medicine. He obtained a Master in Science in Clinical Investigation from UTHSA and a PhD in Medicine from the Universidad de Valencia, Spain.

He has published more than 260 peer review manuscripts and presented at national and international scientific meetings. He is a member of both pneumonia (community acquired and hospital acquired) guidelines sponsored by the American Thoracic Society of America (ATS)/ and Infectious Diseases Society of America (IDSA). He serves as associate editor for European Respiratory Journal (ERJ)and Respirology

Dr. Masahide Oki, MD, FCCP

Japan

Dr. Oki has been a chief of Department of Respiratory Medicine at National Hospital Organization Nagoya Medical Center since 2009. His main research interest is interventional pulmonology, and he has published a lot of papers in the field. He received Shigeto Ikeda Award from the Japan Society of Respiratory Endoscopy in 2014, the WABIP-Dumon Award from the World Association for Bronchology and Interventional Pulmonology in 2016, and Kumagai Award from the Japanese Respiratory Society in 2023

International Speakers

Contact Us

Venue